Certified by Founder Lodge
Fidelity Investments
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Fidelity, our goal is to make financial expertise broadly accessible and effective in helping people live the lives they want. We do this by focusing on a diverse set of customers: - from
| Company | Date | Round | Raised |
|---|---|---|---|
 Talos |
May, 10 ,2022 | Series B | $105,000,000 |
 Asimov |
January, 09 ,2023 | Series B | $200,000,000 |
 JIFFY.ai |
March, 09 ,2022 | Series B | $53,000,000 |
 Gopuff |
August, 31 ,2022 | Unknown | $300,000,000 |
 Menlo Micro |
March, 09 ,2022 | Series C | $150,000,000 |
| Talos |
May, 10 ,2022 | Series B | $105,000,000 |
 Evozyne |
September, 28 ,2023 | Series B | $81,000,000 |
| JIFFY.ai |
March, 09 ,2022 | Series B | $53,000,000 |
 Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Menlo Micro |
March, 09 ,2022 | Series C | $150,000,000 |
| Evozyne |
September, 28 ,2023 | Series B | $81,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Kardium Inc. |
June, 12 ,2024 | Unknown | $104,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
